Using Ferumoxytol nanoparticles to boost natural healing cells for facial and jaw bone repair
Repurposing Ferumoxytol Nanoparticles to Promote Orofacial Stem Cell Function for Autotherapies
This project explores whether an existing iron-based medication can help our body's own stem cells grow and repair bone in the face and jaw.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11167761 on NIH RePORTER |
What this research studies
Our bodies have special stem cells in the face and jaw that are great at repairing bone, but we don't fully understand how to use them best. This project looks at a medication called Ferumoxytol, which is already approved for other uses, to see if it can activate these natural healing cells. We want to find out if Ferumoxytol can make these cells grow better, change into bone-forming cells more effectively, and help the body heal itself. The goal is to develop new ways to fix bone defects in the head and face using your own cells.
Who could benefit from this research
Good fit: Patients with craniofacial bone defects who might benefit from regenerative therapies using their own stem cells could be ideal candidates for future applications of this research.
Not a fit: Patients without craniofacial bone defects or those who cannot use their own stem cells for regeneration may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could lead to new treatments for craniofacial bone defects by using a patient's own stem cells, potentially reducing the need for more invasive procedures.
How similar studies have performed: While Ferumoxytol has shown other biomedical properties, its application in activating orofacial stem cells for tissue regeneration is a novel and unexplored area.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Chen, Chi-Der — University of Pennsylvania
- Study coordinator: Chen, Chi-Der
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.